...BRCA2 mutation carriers. Median and mean age for carcinomas were 50 years and 49.3 respectively, significantly younger t...
...BRCA2. In 1995 both genes were identified and cloned, and they demonstrated to have only minimal homology. The conclusio...
...BRCA2-deficient cancers, very little is known of the PARP inhibition effect upon cancers proficient in DNA double-strand...
...BRCA2 splice sites were characterized by transcripts analysis. These results were used to evaluate the ability of nine b...
...BRCA2, Phosphatase and tensin homolog, cellular myelocytomatosis oncogene and NKX3.1 may predict for aggressive high gra...
...BRCA2 mutations and their relationship with female fertility.,Eight relevant studies of female fertility, five of which ...
...BRCA2 mutations, age, conditions that alter the estrogen/androgen ratio, and radiation are proven risk factors. Disease ...
...BRCA2-interacting protein) truncation at the C-terminus in the hd mutant. Here, we report data from a transgenic rescue ...
...BRCA2 mutations. The effectiveness and cost-effectiveness of the Dutch, UK and US screening strategies, which involve ma...
...BRCA2-associated pancreatic cancer treated with the poly-(ADP-ribose) polymerase (PARP) inhibitor ABT-888 (veliparib). W...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2026.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
